With by far more announcements than any of the rest, OpenAI takes the AI industry limelight at the start of the week, from its DevDay 2025 developer event to a new partnership with AMD.
Here are our key takeaways in more detail:
OpenAI’s DevDay 2025 event unveils a new AI agent toolkit, apps in ChatGPT, and new additions to its developer API
AMD and OpenAI ink a multi-year deal to deploy 6 gigawatts worth of AMD AI chips for compute
OpenAI’s mystery wearable with Jony Ive runs into “technical issues,” threatening a delay to 2026
Join us at AI Tangle as we untangle this week's happenings in AI!
HOW TO SCALE FAST WITH AI
Tired of AI experiments going nowhere, do you need AI to start delivering real business value now instead of next year?
Hosted by Mark R. Hinkle on the 8th of October, 7:30 PM EEST, speaker and chief Microsoft architect DeShon Clark reveals why many organizations get stuck in "AI theater" - pilots that impress but don't scale - and how to break through the deadlock.
During these 40 minutes, you will discover:
3 use cases that deliver consistent ROI (and which ones waste millions!)
A governance framework that protects without stunning business
How to transform Azure AI Foundry and Microsoft 365 licenses into real, competitive advantages
What separates organizations that scale from those stuck in perpetual demos
Sound like something that could up your business venture? Sign up for the free online event!
5 QUICK HITS
OpenAI's third run of their annual DevDay event at Fort Mason in San Francisco has come to an end, and with, a variety of announcements.
Following rumors circulating a few days prior to the event, OpenAI's AgentKit took the spotlight, a purpose-built developer toolkit for building, scaling, and shipping AI agents and workflows. OpenAI also announced a push to integrate many consumer apps into ChatGPT with its Apps in ChatGPT and Apps SDK for developers, allowing users to naturally pull apps from its pilot list into a conversation. To top things off, OpenAI also brought Sora 2 and GPT-5 Pro to its developer API, along with its new gpt-realtime-mini voice model and gpt-image-1-mini image model.
Just weeks after signing a $100 billion compute deal with Nvidia, OpenAI has pivoted to one of its biggest competitors, AMD, for a multi-year, multi-billion-dollar AI partnership. The deal will see AMD supply OpenAI with 6 gigawatts worth of AMD chips, with the first gigawatt slated to go online in the second half of 2026. It also gives OpenAI the option to take a roughly 10% stake in AMD, provided the pair hit deployment targets and AMD hits share price ones. As a result of the news, AMD's share price surged as much as 37% in premarket trading.
Beyond Dev Day, however, OpenAI's first device with Jony Ive could be in jeopardy as "technical issues" threaten development, according to a recent article by the Financial Times. The report claims that the voice and mannerisms of the AI assistant have yet to be settled upon, along with figuring out potential privacy concerns and possible budget limitations. Despite the public knowing little about the wearable's actual details, the article concludes that the issues could ultimately delay its release date to 2026. OpenAI acquired Jony Ive's hardware startup, io, for $6.5 billion in May earlier this year, together with its 55 employees.
In a recent blog post shared by DeepMind, the AI research of Google has introduced a new AI agent for code security that it calls CodeMender. The agent builds on Google DeepMind's previous code vulnerability-related projects, such as Big Sleep and OSS-Fuzz, and claims that CodeMender can autonomously detect, patch and rewrite vulnerable code to prevent future exploits. Leveraging a multi-agent approach and a variety of program analysis tools, CodeMender has already found and patched 72 security fixes across open source projects both small and large.
As reported by the Financial Times, biotech firm AstraZeneca has signed a deal worth up to $555 million with San Francisco-based Algen Biotechnologies to use its AlgenBrain AI platform and CRISPR-based tools for early-stage drug discovery in immunology. AstraZeneca will have exclusive rights to develop and commercialize any gene therapies discovered via this collaboration, while Algen will receive an undisclosed upfront payment, along with additional milestone-based payments based on research progress.
4 AI TOOLS
Snapdeck - The Lovable for slides, build a winning deck at the drop of a hat with Snapdeck's AI designs, layouts, themes, charts, and diagrams.
Gensmo - Gensmo is an advanced multimodal search platform that brings your ideas to life, delivering interactive results for outfit inspiration, gift suggestions, or decor matches with ease.
AI EXTRA READ
The Reinforcement Gap (4-min read)
While AI coding continues to improve by leaps and bounds, other, more subjective areas struggle to make the same kind of progress. Discover why the "reinforcement gap" means that certain AI skills develop slower than others, and why it is one of AI's biggest bottlenecks.
MORE FROM THE AIE NETWORK
📻 AI Confidential Podcast - Are LLMs Dead?
💼 The Artificially Intelligent Enterprise - What I Learned About AI from Two Hours in College
💡 AI CIO - The Paradox of AI Reports
🎯 The AI Marketing Advantage - Your Meta AI Chats Are About To Power Ads
What did you think of this newsletter? Let us know!
Your AI Sherpa,
Mark R. Hinkle
Publisher, The Artificially Intelligent
Enterprise (TheAIE) Network
Connect with me on LinkedIn
Follow me on X
